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The transcription factor nuclear factor Y
regulates the proliferation of myeloid progenitor
cells
The transcription factor nuclear factor Y (NF-Y) con-
sists of three subunits; NF-YA, -B and -C, and this com-
plex binds DNA and the basal transcription machinery
through binding of TBP.1 NF-Y targets include cell cycle
related genes and hematopoietic (stem) cell genes such as
cd34 and hoxb4.2 Deletion of both nf-ya alleles in mice
results in embryonic lethality. Inactivation of NF-YA in
mouse embryonic fibroblasts results in a block in prolif-
eration, which is followed by apoptosis.3 A few studies
have been performed addressing the role of NF-Y in
hematopoiesis. Mouse bone marrow (BM) cells overex-
pressing NF-YA are biased towards primitive
hematopoiesis and show increased repopulating ability
after bone marrow transplantation.2 During macrophage
differentiation NF-Y shows increasing binding activity to
several promoters4 and NF-Y has been shown to mediate
the IL-6 response in BM cells, which results in induction
of macrophage differentiation.5
Mantovani et al. constructed a mutant form of NF-YA
(YAm29), defective in DNA-binding and shown to have a
dominant-negative effect on transcription regulation by
wild type NF-Y.6,7 To determine the requirement of NF-Y
in myelopoiesis, we cloned the YAm29 cDNA in the
LZRS vector,8 containing an IRES-GFP expression cas-
sette. Mouse BM cells were transduced with YAm29 (effi-
ciency of 23±8.9%, 3 independent experiments) as
described earlier.9 As a control we transduced cells with
an empty vector (efficiency of 14.5±8.1%). One day after
transduction, GFP+ cells were sorted by flowcytometry
and analyzed. Endogenous NF-YA expression was detect-
ed by Western blot analysis in the control cells. Clear
overexpression of YAm29 was detected in the GFP+ frac-
tion of the YAm29 transduced cells (Figure 1A). To deter-
mine whether expression of YAm29 repressed the
expression of NF-Y target genes we measured the levels
of Hoxb4 mRNA by qPCR, performed as previously
described.7 Hoxb4 mRNA levels were significantly down-
regulated in cells transduced with YAm29 compared to
cells transduced with empty vector, indicating that
YAm29 effectively represses NF-Y function (Figure 1B).
To determine the effect of YAm29 expression on colony
formation, GFP+ cells were plated in methylcellulose and
colonies were counted after 5-7 days. Transduction with
YAm29 resulted in a reduction of granulocytic (CFU-G)
and monocytic (CFU-M) colony formation by 70±6%
(p<0.01) and 44±19% (p<0.1) respectively, compared to
cells transduced with empty vector (Figure 1C). In addi-
tion, transduction with YAm29 resulted in a reduction of
the size of both colony types (data not shown). The data
suggest that NF-Y is required for the proliferation of
myeloid progenitor cells. 
To quantify the inhibitory effect of YAm29 on prolifer-
ation, cells were grown in liquid culture. The empty vec-
tor transduced population expanded faster than the
YAm29 transduced population, resulting in a three-fold
difference in cell numbers on day 6 (Figure 2A). To inves-
tigate the effect of YAm29 on maturation, the differenti-
ation marker MAC-1 was used. MAC-1 is expressed on
maturing myeloid cells, beyond the colony-forming unit
(CFU) stage.11 The percentage of MAC-1 positive cells
increased more rapidly within the YAm29 transduced
population than in the control population. After eight
days, all YAm29 transduced cells were MAC-1 positive
(Figure 2B), while in the control population around 17%
of the cells were still MAC-1 negative. This suggested
that the immature cells in the control population still pro-
liferated and in the YAm29 transduced population prolif-
eration of immature cells was inhibited. The expansion of
the MAC-1 negative cell fraction was calculated by mul-
tiplying the total amount of cells with the percentage of
MAC-1 negative cells. This revealed that proliferation of
the YAm29 transduced immature MAC-1 negative popu-
lation was completely impaired, whereas the MAC-1
negative population in the empty vector transduced cells
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Figure 1. YAm29 inhibits clonogenic growth of mouse bone mar-
row cells. Bone marrow cells were transduced with YAm29 or
empty vector and after 24 hours transduction cells were sorted for
GFP positivity by flow cytometry. (A) Complete cell lysates were
resolved on SDS-PAGE and stained using NF-YA specific antibody
(C-18, Santa Cruz) and ß-Actin (A-5441, Sigma) specific antibody.
(B) Quantitave PCR for HoxB4 (Mm01307004_mH, Applied
Biosystems) and 18S rRNA (cat no. 4310893E, AB). Experiments
were repeated three times and p values were determined with a
t-test. The expression of HoxB4 was significantly lower in YAm29
expressing cells (p<0.05) (C) For the semi-solid culture 5000 cells
were plated per mL methylcellulose medium. Granulocyte colony-
forming units (CFU-G) and monocyte colony-forming units (CFU-M)
were counted fiveseven days later using an inverted microscope.
The amount of colonies is shown after transduction with YAm29
as a percentage relative to the amount of colonies after transduc-
tion with empty vector. Experiments were repeated three times
independently. There was a statistically significant difference in
the amount of colonies (CFU-G; p<0.05, CFU-M; p<0.1) between
the two treatments.
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still expanded (Figure 2C). The intensity of the MAC-1
marker, determined by mean fluorescence (Figure 2B),
which correlates with the maturation stage of the cells,
increased at an almost comparable rate for both popula-
tions. This suggested that YAm29 expression did not
severely affect differentiation. 
DNA histograms of the YAm29 transduced and empty
vector transduced cells showed no difference in the
amount of cells in the different phases of the cell cycle
(data not shown). To investigate whether the loss of expan-
sion in YAm29 transduced BM cells was accompanied by
increased apoptosis, we stained the BM cells with annex-
in V. Within the MAC-1 negative population, 9-10%
annexin V positive cells were found the first two days in
the culture of cells transduced with the empty vector,
whereas 23-25% of annexin V positive cells were found
the first two days in the culture of cells transduced with
YAm29 (Figure 2D). This higher percentage of annexin V
positivity was not found in the YAm29 transduced MAC-
1 positive population. These data suggest that loss of NF-
Y function resulted in increased apoptosis, specifically in
MAC-1 negative myeloid progenitor cells.
To summarize, we show that blocking the function of
NF-Y in BM cells results in a significant reduction of CFU-
G and CFU-M formation both in size and number. BM
cells transduced with YAm29 were still able to become
MAC-1 positive at a comparable pace as cells transduced
with empty vector, suggesting that maturation was not
severely affected. However, YAm29 transduction com-
pletely inhibited the expansion of the immature, MAC-1
negative population. This suggests that YAm29 inhibits
expansion of the myeloid progenitor cells, explaining the
overall decrease in myeloid cells in the liquid and colony
assays upon YAm29 expression and indicating that func-
tional NF-Y is needed for expansion of the myeloid pro-
genitor fraction.
NF-Y is a complex of three proteins. Zhu et al.2 showed
that overexpression of only the NF-YA subunit promotes
the expansion of hematopoietic stem cells. Here we show
that inhibiting the function of the trimeric NF-Y complex,
with a dominant negative protein, reduces the expansion
of progenitor BM cells. Together, these data suggest that
the increased expansion of immature BM cells upon over-
expression of only the NF-YA subunit is through
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Figure 2. YAm29 inhibits proliferation of MAC-1 negative cells. For the liquid cultures bone marrow cells were grown in the same man-
ner as used for the colony assays, but lacking methylcellulose. Cells were grown in 96 well plates. (A) Bone marrow cells were trans-
duced with control or YAm29 retrovirus (t= -1) and GFP+ cells were grown in liquid medium. Cells were counted on a flowcytometer by
adding a constant amount of beads to each sample (flow-check beads, Beckman coulter). There was a statistically significant difference
in the amount of cells on day 6 (p<0.05) between the two treatments. (B) Transduced cells were incubated with MAC-1 antibody (1:100,
Pharmingen, the Netherlands, Alphen a/d Rijn) to discriminate between immature and mature myeloid cells. The flowcytometer dot
plots are shown, forward scatter (FS) against MAC-1 expression, from day 1 to day 8. Also shown is the mean intensity of the MAC-1
expression (C) The expansion of MAC-1 negative cells was calculated by multiplying the percentage of MAC-1 negative cells, from panel
B, with the total amount of cells, from panel A. There was a statistically significant difference in the amount of cells on day 6 (p<0.05)
between the two treatments (D) Cells were double stained with MAC-1 antibody and annexin V and analyzed by flowcytometry to assess
the percentage of apoptotic cells.11 The increase in annexin V in the YAm29 transduced cells in the MAC-1 negative fraction was signif-
icantly higher on day 0 (p<0.05) and day 1 (p<0.05). 
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increased activity of the trimeric NF-Y complex. There-
fore, the size of the pool of immature hematopoietic cells
may be regulated through (de-)activating NF-Y. 
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Congenital sideroblastic anemia associated 
with germline polymorphisms reducing expression
of FECH
The sideroblastic anemias (SAs) are disorders of inef-
fective erythropoiesis, collectively characterized by
abnormal Prussian blue-positive granules (i.e., iron-
stuffed mitochondria) that encircle marrow erythroblast
nuclei to form ringed sideroblast cells.1 SAs are usually
acquired, but occasionally congenital. While the causes
of the common acquired forms of SA remain largely
unknown, the molecular genetics of several of the inher-
ited forms of SA is now well understood.2,3 For instance,
X-linked SA is often associated with germline mutations
in the erythroid-specfic isoform of 5-aminolevulinate
synthase (ALAS2), and several mitochondrial metabolic
defects have also been linked to inherited SAs. However,
there are still many congenital SA cases of unknown
molecular origin.
The precise relationship between SA and erythropoiet-
ic protoporphyria (EPP, MIM #177000) is unclear. A sub-
stantial fraction of patients with EPP have anemia (48%
of women and 33% of men in the largest series), which
is usually mild and associated with diminished iron
stores.4 Ferrochelatase, the enzyme deficient in EPP, is
encoded by the FECH locus at 18q21.3 and catalyzes the
final step in heme biosynthesis: addition of ferrous iron
to the protoporphyrin ring.5 In one analysis of 9 EPP
patients, scattered ringed sideroblasts were observed by
light microscopy in the bone marrows of 7 patients,
while mitochondrial electron energy-loss spectroscopy
(EELS) indicated SA-like iron compounds in all 9 sam-
ples.6 Additionally, a 1973 report described a case of EPP
with fatal liver disease associated with SA-like features.7
Despite these observations, most idiopathic acquired SA
cases do not have FECH mutations, even though modest
elevations of erythrocyte protoporphyrin levels are com-
mon in this group.3,8
Here we describe a child who presented with congeni-
tal SA of unclear etiology, in whom we detected marked-
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Figure 1. Iron stain of bone marrow aspirate demonstrating ringed
sideroblasts. Numerous ringed sideroblasts (arrows) comprising
70-80% of the bone marrow erythroid cells are evident. (Prussian
blue reaction, 400X, obtained with Olympus BX 40 microscope
(Olympus, Tokyo, Japan) equipped with an Uplan 100 x/1.30 NA
oil apochromatic lens and Olympus Q-color 3 CCD camera. Image
processed for color balance using Adobe Photoshop CS2 (Adobe
Systems, San José, CA, USA). 
